258 related articles for article (PubMed ID: 37390222)
1. Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells.
Palmer WH; Leaton LA; Campos Codo A; Crute B; Roest J; Zhu S; Petersen J; Tobin RP; Hume PS; Stone M; van Bokhoven A; Gerich ME; McCarter MD; Zhu Y; Janssen WJ; Vivian JP; Trowsdale J; Getahun A; Rossjohn J; Cambier J; Loh L; Norman PJ
Sci Immunol; 2023 Jun; 8(84):eade5343. PubMed ID: 37390222
[TBL] [Abstract][Full Text] [Related]
2. KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target.
Wei Y; Ren X; Galbo PM; Moerdler S; Wang H; Sica RA; Etemad-Gilbertson B; Shi L; Zhu L; Tang X; Lin Q; Peng M; Guan F; Zheng D; Chinai JM; Zang X
Sci Immunol; 2021 Jul; 6(61):. PubMed ID: 34244312
[TBL] [Abstract][Full Text] [Related]
3. Mystery Checkpoint Revealed: KIR3DL3 Finally Found a Ligand in HHLA2.
Campbell KS
Cancer Immunol Res; 2021 Feb; 9(2):128. PubMed ID: 33536266
[TBL] [Abstract][Full Text] [Related]
4. HHLA2 immune-regulatory roles in cancer.
Mortezaee K
Biomed Pharmacother; 2023 Jun; 162():114639. PubMed ID: 37011487
[TBL] [Abstract][Full Text] [Related]
5. Conservation, Extensive Heterozygosity, and Convergence of Signaling Potential All Indicate a Critical Role for KIR3DL3 in Higher Primates.
Leaton LA; Shortt J; Kichula KM; Tao S; Nemat-Gorgani N; Mentzer AJ; Oppenheimer SJ; Deng Z; Hollenbach JA; Gignoux CR; Guethlein LA; Parham P; Carrington M; Norman PJ
Front Immunol; 2019; 10():24. PubMed ID: 30745901
[TBL] [Abstract][Full Text] [Related]
6. KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1.
Bhatt RS; Berjis A; Konge JC; Mahoney KM; Klee AN; Freeman SS; Chen CH; Jegede OA; Catalano PJ; Pignon JC; Sticco-Ivins M; Zhu B; Hua P; Soden J; Zhu J; McDermott DF; Arulanandam AR; Signoretti S; Freeman GJ
Cancer Immunol Res; 2021 Feb; 9(2):156-169. PubMed ID: 33229411
[TBL] [Abstract][Full Text] [Related]
7. KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy.
Li Y; Lv C; Yu Y; Wu B; Zhang Y; Lang Q; Liang Z; Zhong C; Shi Y; Han S; Xu F; Tian Y
J Adv Res; 2023 May; 47():137-150. PubMed ID: 35933091
[TBL] [Abstract][Full Text] [Related]
8. Protocol for evaluating antitumor activity of KIR3DL3 blockade in an NK cell-based xenogeneic lung tumor model.
Ren X; Corrigan DT; Zang X
STAR Protoc; 2022 Dec; 3(4):101818. PubMed ID: 36386885
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of KIR3DL3.
Trundley AE; Hiby SE; Chang C; Sharkey AM; Santourlidis S; Uhrberg M; Trowsdale J; Moffett A
Immunogenetics; 2006 Jan; 57(12):904-16. PubMed ID: 16391939
[TBL] [Abstract][Full Text] [Related]
10. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
[TBL] [Abstract][Full Text] [Related]
11. Regulation of KIR3DL3 Expression via Mirna.
Nutalai R; Gaudieri S; Jumnainsong A; Leelayuwat C
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31405037
[TBL] [Abstract][Full Text] [Related]
12. Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3.
Trompeter HI; Gómez-Lozano N; Santourlidis S; Eisermann B; Wernet P; Vilches C; Uhrberg M
J Immunol; 2005 Apr; 174(7):4135-43. PubMed ID: 15778373
[TBL] [Abstract][Full Text] [Related]
13. Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation.
Cooley S; Parham P; Miller JS
Blood; 2018 Mar; 131(10):1053-1062. PubMed ID: 29358179
[TBL] [Abstract][Full Text] [Related]
14. Report from the Killer-cell Immunoglobulin-like Receptors (KIR) component of the 17th International HLA and Immunogenetics Workshop.
Misra MK; Augusto DG; Martin GM; Nemat-Gorgani N; Sauter J; Hofmann JA; Traherne JA; González-Quezada B; Gorodezky C; Bultitude WP; Marin W; Vierra-Green C; Anderson KM; Balas A; Caro-Oleas JL; Cisneros E; Colucci F; Dandekar R; Elfishawi SM; Fernández-Viña MA; Fouda M; González-Fernández R; Große A; Herrero-Mata MJ; Hollenbach SQ; Marsh SGE; Mentzer A; Middleton D; Moffett A; Moreno-Hidalgo MA; Mossallam GI; Nakimuli A; Oksenberg JR; Oppenheimer SJ; Parham P; Petzl-Erler ML; Planelles D; Sánchez-García F; Sánchez-Gordo F; Schmidt AH; Trowsdale J; Vargas LB; Vicario JL; Vilches C; Norman PJ; Hollenbach JA
Hum Immunol; 2018 Dec; 79(12):825-833. PubMed ID: 30321631
[TBL] [Abstract][Full Text] [Related]
15. Nature of allelic sequence polymorphism at the KIR3DL3 locus.
Jones DC; Hiby SE; Moffett A; Trowsdale J; Young NT
Immunogenetics; 2006 Aug; 58(8):614-27. PubMed ID: 16823588
[TBL] [Abstract][Full Text] [Related]
16. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition.
Pietra G; Romagnani C; Falco M; Vitale M; Castriconi R; Pende D; Millo E; Anfossi S; Biassoni R; Moretta L; Mingari MC
Eur J Immunol; 2001 Dec; 31(12):3687-93. PubMed ID: 11745389
[TBL] [Abstract][Full Text] [Related]
17. HLA class I-restricted recognition of an HIV-derived epitope peptide by a human T cell receptor alpha chain having a Vdelta1 variable segment.
Ueno T; Tomiyama H; Fujiwara M; Oka S; Takiguchi M
Eur J Immunol; 2003 Oct; 33(10):2910-6. PubMed ID: 14515275
[TBL] [Abstract][Full Text] [Related]
18. CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells.
Björkström NK; Béziat V; Cichocki F; Liu LL; Levine J; Larsson S; Koup RA; Anderson SK; Ljunggren HG; Malmberg KJ
Blood; 2012 Oct; 120(17):3455-65. PubMed ID: 22968455
[TBL] [Abstract][Full Text] [Related]
19. CD8 T cells expressing killer Ig-like receptors and NKG2A are present in cord blood and express a more naïve phenotype than their counterparts in adult blood.
Warren HS; Rana PM; Rieger DT; Hewitt KA; Dahlstrom JE; Kent AL
J Leukoc Biol; 2006 Jun; 79(6):1252-9. PubMed ID: 16574769
[TBL] [Abstract][Full Text] [Related]
20. Distribution of killer cell immunoglobulin-like receptor genes in Thai blood donors.
Tammakorn C; Mongkolsuk T; Thammanichanond D; Pakakasama S; Kitpoka P
J Med Assoc Thai; 2011 Jun; 94(6):738-42. PubMed ID: 21696085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
